<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the femoropopliteal arteries - Kayssi, A - 2019 | Cochrane Library</title> <meta content="Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the femoropopliteal arteries - Kayssi, A - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012510.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the femoropopliteal arteries - Kayssi, A - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012510.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012510.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the femoropopliteal arteries" name="citation_title"/> <meta content="Ahmed Kayssi" name="citation_author"/> <meta content="Sunnybrook Health Sciences Centre, University of Toronto" name="citation_author_institution"/> <meta content="Ahmed.Kayssi@sunnybrook.ca" name="citation_author_email"/> <meta content="Wissam Al‐Jundi" name="citation_author"/> <meta content="Sunnybrook Health Sciences Centre, University of Toronto" name="citation_author_institution"/> <meta content="Giuseppe Papia" name="citation_author"/> <meta content="Sunnybrook Health Sciences Centre, University of Toronto" name="citation_author_institution"/> <meta content="Daryl S Kucey" name="citation_author"/> <meta content="Sunnybrook Health Sciences Centre, University of Toronto" name="citation_author_institution"/> <meta content="Thomas Forbes" name="citation_author"/> <meta content="Toronto General Hospital, University of Toronto" name="citation_author_institution"/> <meta content="Dheeraj K Rajan" name="citation_author"/> <meta content="University of Toronto" name="citation_author_institution"/> <meta content="Richard Neville" name="citation_author"/> <meta content="Inova Heart and Vascular Institute" name="citation_author_institution"/> <meta content="Andrew D Dueck" name="citation_author"/> <meta content="Sunnybrook Health Sciences Centre, University of Toronto" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD012510.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/01/26" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012510.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012510.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012510.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Femoral Artery; *Popliteal Artery; *Stents; Amputation, Surgical; Angioplasty, Balloon [adverse effects, *methods]; Ankle Brachial Index; Constriction, Pathologic [etiology, mortality, therapy]; Randomized Controlled Trials as Topic; Recurrence; Vascular Patency" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012510.pub2&amp;doi=10.1002/14651858.CD012510.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="p32VIvbS";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012510\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012510\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","pt","hr","fr","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012510.pub2",title:"Drug\\u2010eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in\\u2010stent restenosis of the femoropopliteal arteries",firstPublishedDate:"Jan 26, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=p32VIvbS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012510.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012510.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012510.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012510.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012510.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012510.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012510.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012510.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012510.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012510.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3296 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012510.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-sec-0104"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-sec-0067"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-sec-0098"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/appendices#CD012510-sec-0109"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/table_n/CD012510StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/table_n/CD012510StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the femoropopliteal arteries </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information#CD012510-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Ahmed Kayssi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information#CD012510-cr-0003">Wissam Al‐Jundi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information#CD012510-cr-0004">Giuseppe Papia</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information#CD012510-cr-0005">Daryl S Kucey</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information#CD012510-cr-0006">Thomas Forbes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information#CD012510-cr-0007">Dheeraj K Rajan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information#CD012510-cr-0008">Richard Neville</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information#CD012510-cr-0009">Andrew D Dueck</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information/en#CD012510-sec-0114">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 26 January 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012510.pub2">https://doi.org/10.1002/14651858.CD012510.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012510-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012510-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012510-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012510-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012510-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD012510-abs-0002">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012510-abs-0014">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012510-abs-0001" lang="en"> <section id="CD012510-sec-0001"> <h3 class="title" id="CD012510-sec-0001">Background</h3> <p>Stents are placed in the femoropopliteal arteries for numerous reasons, such as atherosclerotic disease, the need for dissection, and perforation of the arteries, and can become stenosed with the passage of time. When a stent develops a flow‐limiting stenosis, this process is known as "in‐stent stenosis." It is thought that in‐stent restenosis is caused by a process known as "intimal hyperplasia" rather than by the progression of atherosclerotic disease. Management of in‐stent restenosis may include performing balloon angioplasty, deploying another stent within the stenosed stent to force it open, and creating a bypass to deliver blood around the stent. The role of drug‐eluting technologies, such as drug‐eluting balloons (DEBs), in the management of in‐stent restenosis is unclear. Drug‐eluting balloons might function by coating the inside of stenosed stents with cytotoxic chemicals such as paclitaxel and by inhibiting the hyperplastic processes responsible for in‐stent restenosis. It is important to perform this systematic review to evaluate the efficacy of DEB because of the potential for increased expenses associated with DEBs over uncoated balloon angioplasty, also known as plain old balloon angioplasty (POBA). </p> </section> <section id="CD012510-sec-0002"> <h3 class="title" id="CD012510-sec-0002">Objectives</h3> <p>To assess the safety and efficacy of DEBs compared with uncoated balloon angioplasty in people with in‐stent restenosis of the femoropopliteal arteries as assessed by criteria such as amputation‐free survival, vessel patency, target lesion revascularization, binary restenosis rate, and death. We define "in‐stent restenosis" as 50% or greater narrowing of a previously stented vessel by duplex ultrasound or angiography. </p> </section> <section id="CD012510-sec-0003"> <h3 class="title" id="CD012510-sec-0003">Search methods</h3> <p>The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase, and CINAHL databases and the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to November 28, 2017. Review authors also undertook reference checking to identify additional studies. </p> </section> <section id="CD012510-sec-0004"> <h3 class="title" id="CD012510-sec-0004">Selection criteria</h3> <p>We included all randomized controlled trials that compared DEBs versus uncoated balloon angioplasty for treatment of in‐stent restenosis in the femoropopliteal arteries. </p> </section> <section id="CD012510-sec-0005"> <h3 class="title" id="CD012510-sec-0005">Data collection and analysis</h3> <p>Two review authors (AK, WA) independently selected appropriate trials and performed data extraction, assessment of trial quality, and data analysis. The senior review author (AD) adjudicated any disagreements. </p> </section> <section id="CD012510-sec-0006"> <h3 class="title" id="CD012510-sec-0006">Main results</h3> <p>Three trials that randomized a combined total of 263 participants met the review inclusion criteria. All three trials examined the treatment of symptomatic in‐stent restenosis within the femoropopliteal arteries. These trials were carried out in Germany and Austria and used paclitaxel as the agent in the drug‐eluting balloons. Two of the three trials were industry sponsored. Two companies manufactured the drug‐eluting balloons (Eurocor, Bonn, Germany; Medtronic, Fridley, Minnesota, USA). The trials examined both anatomical and clinical endpoints. We noted heterogeneity in the frequency of bailout stenting deployment between studies as well as in the dosage of paclitaxel applied by the DEBs. Using GRADE assessment criteria, we determined that the certainty of evidence presented was very low for the outcomes of amputation, target lesion revascularization, binary restenosis, death, and improvement of one or more Rutherford categories. Most participants were followed up to 12 months, but one trial followed participants for up to 24 months. </p> <p>Trial results show no difference in the incidence of amputation between DEBs and uncoated balloon angioplasty. DEBs showed better outcomes for up to 24 months for target lesion revascularization (odds ratio (OR) 0.05, 95% confidence Interval (CI) 0.00 to 0.92 at six months; OR 0.24, 95% CI 0.08 to 0.70 at 24 months) and at six and 12 months for binary restenosis (OR 0.28, 95% CI 0.14 to 0.56 at six months; OR 0.34, 95% CI 0.15 to 0.76 at 12 months). Participants treated with DEBs also showed improvement of one or more Rutherford categories at six and 12 months (OR 1.81, 95% CI 1.02 to 3.21 at six months; OR 2.08, 95% CI 1.13 to 3.83 at 12 months). Data show no clear differences in death between DEBs and uncoated balloon angioplasty. Data were insufficient for subgroup or sensitivity analyses to be conducted. </p> </section> <section id="CD012510-sec-0007"> <h3 class="title" id="CD012510-sec-0007">Authors' conclusions</h3> <p>Based on a meta‐analysis of three trials with 263 participants, evidence suggests an advantage for DEBs compared with uncoated balloon angioplasty for anatomical endpoints such as target lesion revascularization (TLR) and binary restenosis, and for one clinical endpoint ‐ improvement in Rutherford category post intervention for up to 24 months. However, the certainty of evidence for all these outcomes is very low due to the small number of included studies and participants and the high risk of bias in study design. Adequately powered and carefully constructed randomized controlled trials are needed to adequately investigate the role of drug‐eluting technologies in the management of in‐stent restenosis. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012510-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012510-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012510-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012510-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012510-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD012510-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012510-abs-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD012510-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012510-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012510-abs-0015">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012510-abs-0005" lang="en"> <h3>Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for stenosis of stents in lower limb arteries </h3> <p><b>Background</b><br/> Many people have disease in their leg arteries that may develop into a blockage and lead to loss of circulation and subsequent pain, skin ulcers, and amputation of the leg. In an effort to prevent lack of blood from harming the leg, procedures can be performed to bypass the blocked artery using a vein or an artificial graft, or to cross it with a wire and open it with a balloon, then place a stent to help prevent the blockage from happening again. Although stents are very strong and can last a long time, it is possible that a stent inside an artery might at times become narrower, and eventually can become blocked. This process is known as "in‐stent restenosis." A blocked stent can be treated in several ways, such as sucking out the clot or ballooning it, or placing another stent inside the stent that failed. Although all treatment options offer advantages and disadvantages, there have been advancements in the technologies available to treat this problem. One of these advancements requires covering the balloon used to treat the stent blockage with a cytotoxic drug used in chemotherapy, to slow down the blockage process after the stent is treated. Such specially prepared balloons, known as "drug‐eluting balloons," have shown encouraging results for treating patients with artery disease in the leg. </p> <p><b>Review question</b><br/> The goal of this review was to determine how drug‐eluting balloon (DEB) angioplasty compares with traditional uncoated balloon angioplasty, also known as plain old balloon angioplasty (POBA), for the treatment of in‐stent restenosis in stents placed in leg arteries. </p> <p><b>Study characteristics</b><br/> Our review included three clinical trials that randomized 263 participants (most recent search ‐ November 28, 2017). Trials included leg arteries at and above the knee and were carried out in Europe; all used DEBs that contained the chemical known as "paclitaxel." Two companies manufactured the DEBs: Eurocor and Medtronic. Most study participants were followed for six or more months; this is called "follow‐up." </p> <p><b>Key results</b><br/> Results showed that DEBs were not better for participants than uncoated balloon angioplasty with regard to the need for amputation. At 24 months of follow‐up, DEBs were associated with fewer target lesion revascularizations, which refers to the need to perform a procedure on a stent that had already been treated with a DEB or an uncoated balloon angioplasty for in‐stent restenosis. DEBs were also found to have better binary restenosis rates, which refers to the percentage of treated stents that develop new stenosis after they have been treated with a DEB or an uncoated balloon angioplasty. Finally, more people who were treated with DEBs described improvement in their leg symptoms, as measured by a change in their Rutherford category. DEBs were not found to be better for participants than uncoated balloon angioplasty with regard to patient death. </p> <p><b>Certainty of the evidence</b><br/> The certainty of the evidence presented was very low because we identified only three studies with small numbers of participants, and because many participants in those studies were lost to follow‐up. Furthermore, risk of performance and attrition bias was significant, as was risk of other biases, due to lack of accounting for the type of stent treated and the need for bailout stenting. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012510-sec-0104" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012510-sec-0104"></div> <h3 class="title" id="CD012510-sec-0105">Implications for practice</h3> <section id="CD012510-sec-0105"> <p>All three included trials were powered to detect anatomical rather than clinically relevant endpoints (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). Our analysis showed an advantage for DEB over uncoated balloon angioplasty for treatment of in‐stent restenosis for up to two years in some domains. However, the certainty of the evidence is generally very low because of the small number of included studies and the risk of bias in those studies. As such, evidence is insufficient at present to show the superiority of DEB over uncoated balloon angioplasty for treatment of in‐stent restenosis. This has important implications for practice, given the increased costs associated with the use of DEBs, which are generally more expensive than uncoated balloon angioplasty catheters. </p> </section> <h3 class="title" id="CD012510-sec-0106">Implications for research</h3> <section id="CD012510-sec-0106"> <p>To properly evaluate the role of DEBs in treating patients with in‐stent restenosis, appropriately powered, independently funded clinical trials are needed to generate rigorous and reliable data that can be used in a future iteration of this review and that answer questions that are clinically relevant to patients. Questions that can be answered in future trials involve the characteristics of stents that would benefit most from DEB angioplasty for in‐stent restenosis and the effective dose of paclitaxel that would prevent further restenosis. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012510-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012510-sec-0036"></div> <div class="table" id="CD012510-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Drug‐eluting balloon angioplasty at 6 months compared to uncoated balloon angioplasty at 6 months for in‐stent restenosis of the femoropopliteal arteries</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Drug‐eluting balloon angioplasty at 6 months compared to uncoated balloon angioplasty at 6 months for in‐stent restenosis of the femoropopliteal arteries</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with in‐stent restenosis of the femoropopliteal arteries<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> drug‐eluting balloon angioplasty at 6 months<br/> <b>Comparison:</b> uncoated balloon angioplasty at 6 months </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with uncoated balloon angioplasty</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with drug‐eluting balloon angioplasty</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Amputation</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>263</p> <p>(3 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> VERY LOW<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None of the 3 included studies reported any major or minor amputations during follow‐up. Amputation‐free survival was not an outcome in the included studies </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Target lesion revascularization (TLR)<br/> Follow‐up: 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.05<br/> (0.00 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>206 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000<br/> (0 to 193) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Binary restenosis<br/> Follow‐up: 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.28<br/> (0.14 to 0.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>189<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>407 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>161 per 1000<br/> (88 to 277) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Death</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.93<br/> (0.13 to 6.71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>263</p> <p>(3 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/> VERY LOW<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>8 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>7 per 1000</p> <p>(1 to 49)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Improvement ≥ 1 Rutherford category<br/> Follow‐up: 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.81<br/> (1.02 to 3.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>193<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>427 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>574 per 1000<br/> (432 to 705) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> CI: confidence interval; OR: odds ratio; RCT: randomized controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels because of significant risk of performance and attrition bias, the small numbers of studies and participants, and other biases due to lack of accounting for the type of stent being treated and need for bailout stenting. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012510-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012510-sec-0037"></div> <section id="CD012510-sec-0038"> <h3 class="title" id="CD012510-sec-0038">Description of the condition</h3> <p>Peripheral arterial disease (PAD) of the lower extremities is closely associated with atherosclerosis, a progressive and chronic disease process that leads to hardened vessels and decreased blood flow (<a href="./references#CD012510-bbs2-0032" title="StaryH , ChandlerAB , GlagovS , GuytonJR , InsullW , RosenfeldME , et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation1994;89(5):2462‐78. ">Stary 1994</a>). Although many people with PAD of the lower extremities are asymptomatic, others present with a variety of symptoms, including pain with walking (intermittent claudication), pain at rest, and tissue loss in the affected limbs (<a href="./references#CD012510-bbs2-0025" title="McDermottMM , GreenlandP , LiuK , GuralnikJM , CriquiMH , DolanNC , et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. Journal of the American Medical Association2001;286(13):1599‐606. ">McDermott 2001</a>). PAD is a highly prevalent condition that increases with age and occurs in more than 10% of individuals above the age of 60 (<a href="./references#CD012510-bbs2-0019" title="CriquiMH , AboyansV . Epidemiology of peripheral artery disease. Circulation Research2015;116(9):1509‐26. ">Criqui 2015</a>). </p> <p>Numerous treatment modalities have been used for the management of PAD of the lower extremities. Medical therapies aim to arrest the progression of atherosclerotic disease and improve clinical outcomes by modifying patient risk factors (<a href="./references#CD012510-bbs2-0014" title="AliFN , CarmanTL . Medical management for chronic atherosclerotic peripheral arterial disease. Drugs2012;72(16):2073‐85. ">Ali 2012</a>). Open surgical and endovascular interventions are used in conjunction with medical therapies to improve blood delivery to ischemic tissues by bypassing or otherwise opening arterial blockages with wires, catheters, and other specialized devices (<a href="./references#CD012510-bbs2-0018" title="ConteMS , PomposelliFB , ClairDG , GeraghtyPJ , McKinseyJF , MillsJL , et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. Journal of Vascular Surgery2015;61(3 Suppl):2S‐41S. ">Conte 2015</a>). </p> <p>Of the growing number of interventions available for treating patients with lower extremity PAD, deployment of stents across a stenotic or occluded arterial segment has become a routine practice in certain circumstances, such as with long lesions and those that do not respond well to balloon angioplasty alone (<a href="./references#CD012510-bbs2-0027" title="Ontario Health Technology Advisory Committee. Stenting for peripheral artery disease of the lower extremities: an evidence‐based analysis. Ontario Health Technology Assessment Series2010;10(18):1‐88. ">OHTAC 2010</a>). Stenting provides the mechanical support required to maintain the patency of arterial lesions, but its effectiveness is limited by the occurrence of neointimal proliferation, known as "intimal hyperplasia," and by overgrowth of the inner lining of the artery within the stent. This process, known as "in‐stent restenosis," may limit blood flow through the stent and may sometimes result in recurrence of ischemic symptoms (<a href="./references#CD012510-bbs2-0013" title="AlfonsoF , ByrneRA , RiveroF , KastratiA . Current treatment of in‐stent restenosis. Journal of the American College of Cardiology2014;63(24):2659‐73. ">Alfonso 2014</a>). </p> </section> <section id="CD012510-sec-0039"> <h3 class="title" id="CD012510-sec-0039">Description of the intervention</h3> <p>Numerous endovascular interventions have been described for the treatment of in‐stent restenosis, including repeat uncoated balloon angioplasty, also known as "plain old balloon angioplasty (POBA)" alone, cutting balloon angioplasty, angioplasty with drug‐eluting balloons (DEBs), repeat stenting, and atherectomy (<a href="./references#CD012510-bbs2-0031" title="SinghGD , ArmstrongEJ , LairdJR . Femoropopliteal in‐stent restenosis: current treatment strategies. Journal of Cardiovascular Surgery2014;55(3):325‐33. ">Singh 2014</a>). </p> <p>For all of these interventions, a wire is used first to cross the stenotic or occlusive lesion within the stent before treatment can be administered. Use of DEBs requires pre‐dilation of the stenotic lesion with a plain balloon. A second balloon is then used to coat the inside of the stent with a cytotoxic chemical in the hope of reducing neointimal proliferation. </p> </section> <section id="CD012510-sec-0040"> <h3 class="title" id="CD012510-sec-0040">How the intervention might work</h3> <p>Uncoated balloon angioplasty has been used widely and successfully for the treatment of lower extremity PAD and in‐stent restenosis, but its use is limited by recurrence of the neointimal hyperplastic process. DEBs address this limitation by applying a chemical to the stent that exerts an antiproliferative effect and arrests the restenotic process (<a href="./references#CD012510-bbs2-0034" title="WaksmanR , PakalaR . Drug‐eluting balloon: the comeback kid?. Circulation Cardiovascular Interventions2009;2(4):352‐8. ">Waksman 2009</a>). </p> <p>The most commonly used DEB cytotoxic agent is the taxane paclitaxel, a chemotherapeutic medication that exerts its cytotoxic effect by stabilizing microtubules (<a href="./references#CD012510-bbs2-0024" title="MarupudiNI , HanJE , LiKW , RenardVM , TylerBM , BremH . Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opinion on Drug Safety2007;6(5):609‐21. ">Marupudi 2007</a>). Paclitaxel is a safe and effective DEB agent for treatment of PAD and has been used successfully to decrease the incidence of binary restenosis in femoropopliteal vessels (<a href="./references#CD012510-bbs2-0016" title="CanaudL , OzdemirBA , BelliAM , LoftusIM , ThompsonMM , HinchliffeRJ . Infrainguinal angioplasty with drug‐eluting stents and balloons. Journal of Vascular Surgery2014;59(6):1721‐36. ">Canaud 2014</a>). </p> </section> <section id="CD012510-sec-0041"> <h3 class="title" id="CD012510-sec-0041">Why it is important to do this review</h3> <p>Numerous prospective studies have compared DEB versus uncoated balloon angioplasty for treatment of in‐stent restenosis. DEBs have shown promising results in the treatment of coronary in‐stent restenosis (<a href="./references#CD012510-bbs2-0023" title="IndermuehleA , BahlR , LanskyAJ , FroehlichGM , KnappG , TimmisA , et al. Drug‐eluting balloon angioplasty for in‐stent restenosis: a systematic review and meta‐analysis of randomised controlled trials. Heart2013;99(5):327‐33. ">Indermuehle 2013</a>). However, the certainty of evidence for their use in femoropopliteal vessels remains unclear. Furthermore, DEB technologies are more expensive and are less widely available than uncoated balloon angioplasty. Our review seeks to assess the efficacy of this intervention and to determine whether it is associated with improved clinical outcomes. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012510-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012510-sec-0042"></div> <p>To assess the safety and efficacy of DEBs compared with uncoated balloon angioplasty in people with in‐stent restenosis of the femoropopliteal arteries as assessed by criteria such as amputation‐free survival, vessel patency, target lesion revascularization, binary restenosis rate, and death. We define "in‐stent restenosis" as 50% or greater narrowing of a previously stented vessel by duplex ultrasound or angiography. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012510-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012510-sec-0043"></div> <section id="CD012510-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012510-sec-0045"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs) that compared drug‐eluting balloons (DEBs) versus uncoated balloon angioplasty for in‐stent restenosis of the femoropopliteal arteries. We define "in‐stent restenosis" as 50% or greater narrowing of a previously stented vessel by duplex ultrasound or angiography. </p> </section> <section id="CD012510-sec-0046"> <h4 class="title">Types of participants</h4> <p>We included people undergoing drug‐eluting or uncoated balloon angioplasty for treatment of in‐stent restenosis of the femoropopliteal arteries. </p> </section> <section id="CD012510-sec-0047"> <h4 class="title">Types of interventions</h4> <p>We sought to compare DEBs versus uncoated balloon angioplasty for treatment of in‐stent restenosis of femoropopliteal arteries. Analysis excluded hybrid studies in which DEBs are utilized simultaneously with open surgery, as well as studies that include atherectomy procedures, cutting balloon angioplasty, vascular brachytherapy, and repeat stenting with plain or drug‐eluting stents for management of in‐stent restenosis. </p> </section> <section id="CD012510-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD012510-sec-0049"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012510-list-0001"> <li> <p>Amputation‐free survival, defined as the probability of being alive without loss of the affected lower extremity </p> </li> <li> <p>Vessel patency, both primary and secondary, measured by late lumen loss, target lesion revascularization (TLR), and rate of binary restenosis, defined as 50% or greater narrowing of the vessel by duplex ultrasound or angiography </p> </li> <li> <p>Death</p> </li> </ul> </p> </section> <section id="CD012510-sec-0050"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012510-list-0002"> <li> <p>Change in Rutherford category of PAD</p> </li> <li> <p>Change in the Society for Vascular Surgery Wound, Ischemia, and Foot Infection (WIfI) stage (<a href="./references#CD012510-bbs2-0026" title="MillsJL , ConteMS , ArmstrongDG , PomposelliFB , SchanzerA , SidawyAN , et al. The Society for Vascular Surgery lower extremity threatened limb classification system: risk stratification based on Wound, Ischemia, and foot Infection (WIfI). Journal of Vascular Surgery2014;59(1):220‐34. ">Mills 2014</a>) </p> </li> <li> <p>Change in ankle‐brachial index (ABI)</p> </li> <li> <p>Change in quality of life (QoL) scores, measured by validated instruments such as Short Form 36 (SF‐36) </p> </li> <li> <p>Change in functional walking ability, measured by change in walking distance (on a treadmill or by other walking test) or use of a walking impairment questionnaire </p> </li> </ul> </p> </section> </section> </section> <section id="CD012510-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <p>We applied no language, publication year, or publication status restrictions.</p> <section id="CD012510-sec-0052"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Vascular Information Specialist searched the following databases for relevant trials. </p> <p> <ul id="CD012510-list-0003"> <li> <p>Cochrane Vascular Specialised Register (February 2, 2017).</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 1), in the Cochrane Library, via the Cochrane Register of Studies Online. </p> </li> </ul> </p> <p>See <a href="./appendices#CD012510-sec-0110">Appendix 1</a> for details of the search strategy that were used to search CENTRAL. </p> <p>The Information Specialist also searched the following trials registries for details of ongoing and unpublished studies (February 2, 2017). </p> <p> <ul id="CD012510-list-0004"> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>). </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/ictrp/search/en/" target="_blank">who.int/trialsearch</a>). </p> </li> <li> <p>International Standard Randomized Controlled Trials Number (ISRCTN) Register (<a href="http://www.isrctn.com/" target="_blank">isrctn.com/</a>). </p> </li> </ul> </p> <p>The Information Specialist subsequently conducted top‐up searches of the following databases. </p> <p> <ul id="CD012510-list-0005"> <li> <p>Cochrane Vascular Specialised Register via the Cochrane Register of Studies (CRS‐Web searched from January 1, 2017, to November 28, 2017). </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL), in the Cochrane Library, via the Cochrane Register of Studies Online (CRSO; 2017, Issue 10). </p> </li> <li> <p>MEDLINE (Ovid MEDLINE® Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE® Daily, and Ovid MEDLINE®) (searched from January 1, 2017, to November 28, 2017). </p> </li> <li> <p>Embase Ovid (searched from January 1, 2017, to November 28, 2017).</p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL) Ebsco (searched from January 1, 2017, to November 28, 2017). </p> </li> <li> <p>Allied and Complementary Medicine Database (AMED) Ovid (searched from January 1, 2017, to November 28, 2017). </p> </li> </ul> </p> <p>The Information Specialist modeled search strategies for the listed databases on the search strategy designed for CENTRAL. When appropriate, the search strategies were combined with adaptations of the highly sensitive search strategy designed by Cochrane for identifying RCTs and controlled clinical trials (as described in Chapter 6, of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>; <a href="./references#CD012510-bbs2-0022" title="HigginsJP , AltmanDG , SterneJA , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We have provided search strategies for the major databases in <a href="./appendices#CD012510-sec-0112">Appendix 3</a>. </p> <p>The Information Specialist also performed top‐up searches of the following trials registries on November 28, 2017. </p> <p> <ul id="CD012510-list-0006"> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/trialsearch" target="_blank">who.int/trialsearch</a>). </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>). </p> </li> </ul> </p> </section> <section id="CD012510-sec-0053"> <h4 class="title">Searching other resources</h4> <p>We further examined the bibliographies of studies identified in our search to identify other relevant articles. </p> </section> </section> <section id="CD012510-sec-0054"> <h3 class="title" id="CD012510-sec-0054">Data collection and analysis</h3> <section id="CD012510-sec-0055"> <h4 class="title">Selection of studies</h4> <p>Two review authors (AK, WA) independently selected trials for inclusion in this review from studies identified by the search. A third review author (AD) assessed these trials, determined their suitability, and adjudicated disagreements between the first two review authors. We have outlined in the <a href="#CD012510-sec-0044">Criteria for considering studies for this review</a> section the inclusion criteria used to determine suitability. </p> </section> <section id="CD012510-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (AK, WA) extracted relevant data from the included studies. We collected participant demographics (age, gender, PAD comorbidities, Rutherford PAD category, and baseline ABI), interventions (types and duration of DEBs and uncoated balloon angioplasty), and outcomes (as specified in the <a href="#CD012510-sec-0044">Criteria for considering studies for this review</a> section). A third review author (AD) cross‐checked data. </p> <p>Statistical analysis complied with the standard methods of Cochrane Vascular. We used the computer software package Review Manager 5.3 (RevMan) to perform all statistical analyses and to generate figures (<a href="./references#CD012510-bbs2-0028" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> </section> <section id="CD012510-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (AK, WA) carried out a thorough risk of bias assessment of all included studies using the Cochrane tool for assessing risk of bias (<a href="./references#CD012510-bbs2-0022" title="HigginsJP , AltmanDG , SterneJA , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). This tool assesses bias in six different domains, with each domain receiving a score of high, low, or unclear, depending on each review author’s judgement. A third review author (AD) adjudicated disagreements. We contacted study authors when we needed clarification to better assess risk of bias. </p> </section> <section id="CD012510-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <p>We used the mean difference (MD) to calculate and report continuous outcome measures, such as change in QoL scores. If included studies used different scales, we calculated the standardized mean difference (SMD) instead. We also calculated the associated 95% confidence interval (CI) between the two treatment groups. We calculated and reported dichotomous (binary) outcome measures, such as target lesion revascularization, using the hazard ratio (HR) or the risk ratio (RR) with associated 95% CI, depending on reported data. We carried out analyses at different time points, as reported by the trials. We based our calculations on an intention‐to‐treat approach. </p> </section> <section id="CD012510-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the treated limb for anatomical outcomes such as late lumen loss or binary restenosis. Conversely, the unit of analysis was the patient for outcomes such as quality of life or death. </p> </section> <section id="CD012510-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study authors to inquire about missing or incomplete data. In the event that a significant quantity of data was missing from an included study and attempts to contact study authors were unsuccessful, we assessed the risk of bias associated with including the study in the meta‐analysis and performed a sensitivity analysis. </p> </section> <section id="CD012510-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed interstudy heterogeneity by using a forest plot (<a href="./references#CD012510-bbs2-0029" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JP, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011</a>). We calculated Chi² and I² values to measure the amount of heterogeneity (<a href="./references#CD012510-bbs2-0021" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>). I² values less than 50% indicated low heterogeneity, I² values between 50% and 75% indicated moderate heterogeneity, and I² values greater than 75% indicated significant heterogeneity (<a href="./references#CD012510-bbs2-0020" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> </section> <section id="CD012510-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to construct a funnel plot to assess publication bias when 10 or more studies were available for a particular outcome (<a href="./references#CD012510-bbs2-0033" title="SterneJAC , EggerM , MoherD , editor(s) . Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). </p> </section> <section id="CD012510-sec-0063"> <h4 class="title">Data synthesis</h4> <p>To calculate the pooled treatment effect data, we used random‐effects or fixed‐effect models, depending on the degree of interstudy heterogeneity. If the calculated degree of interstudy heterogeneity was significant (defined as I² greater than 75%), we used the random‐effects model. Otherwise, we used the fixed‐effect model. We calculated 95% CIs for continuous and dichotomous outcome variables, as detailed above. We created a forest plot for each treatment effect as per Cochrane Vascular guidelines. </p> </section> <section id="CD012510-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to perform subgroup analyses by type of DEB, type and dose of pharmacological agent used in the DEB, and clinical severity of PAD, as defined by the change in Rutherford category or the WIfI stage. We also planned to perform subgroup analyses for people with diabetes and for the types of antiplatelet agents prescribed for participants in the included trials. </p> </section> <section id="CD012510-sec-0065"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to exclude studies at high risk of bias from the pooled analysis and to repeat the analysis to assess their impact. We planned to performed a sensitivity analysis by sequentially excluding studies at high risk of bias. </p> <section id="CD012510-sec-0066"> <h5 class="title">"Summary of findings"</h5> <p>We prepared a "Summary of findings" table using the GRADEpro Guideline Development Tool to present the main findings of the review for the time point at which the most relevant data were available from the included studies (<a href="http://www.gradepro.org" target="_blank">www.gradepro.org;</a><a href="./references#CD012510-bbs2-0015" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490‐4. ">Atkins 2004</a>). The population consisted of people with PAD, and we compared DEBs versus uncoated balloon angioplasty for treatment of in‐stent restenosis of femoropopliteal arteries. We included in our "Summary of findings" table the main outcomes listed under <a href="#CD012510-sec-0048">Types of outcome measures</a> that we considered essential for decision‐making. We evaluated the certainty of the evidence using the GRADE approach (<a href="./references#CD012510-bbs2-0030" title="SchünemannHJ , OxmanAD , VistGE , HigginsJP , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011b</a>). We assigned one of four levels of quality: high, moderate, low, or very low, based on overall risk of bias, directness of evidence, inconsistency of results, precision of estimates, and risk of publication bias, as previously described (<a href="./references#CD012510-bbs2-0022" title="HigginsJP , AltmanDG , SterneJA , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012510-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012510-sec-0067"></div> <section id="CD012510-sec-0068"> <h3 class="title">Description of studies</h3> <section id="CD012510-sec-0069"> <h4 class="title">Results of the search</h4> <p>Please see <a href="#CD012510-fig-0001">Figure 1</a> for search results. </p> <div class="figure" id="CD012510-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012510-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012510-sec-0070"> <h4 class="title">Included studies</h4> <p>This review includes three randomized controlled trials that compared DEB versus uncoated balloon angioplasty for treatment of symptomatic in‐stent restenosis of the femoropopliteal arteries (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). The <a href="./references#CD012510-sec-0121" title="">Characteristics of included studies</a> tables present the details of those studies. </p> <p>The three included studies were conducted in Germany ‐ <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a> ‐ and in Austria ‐ <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>. All studies included patients with in‐stent restenosis in the femoropopliteal arteries and used paclitaxel‐coated balloons, although at different dosages (Medtronic IN.PACT Admiral 3.5 mcg/mm² in <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> and <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a> vs Eurocor Freeway 3 mcg/mm² in <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). We also identified two ongoing trials (<a href="./references#CD012510-bbs2-0011" title="NCT01594684 . Cotavance™ paclitaxel‐coated balloon versus uncoated balloon angioplasty for treatment of in‐stent restenosis in SFA and popliteal arteries. clinicaltrials.gov/ct2/show/results/NCT01594684 (date first received May 9, 2012). ">Copa Cabana</a>; <a href="./references#CD012510-bbs2-0012" title="ChiCTR‐TRC‐14004848 . Drug‐eluting balloon versus standard balloon angioplasty for the treatment of in‐stent restenosis in the femoral‐popliteal artery: a randomized, controlled prospective study. chictr.org.cn/hvshowproject.aspx?id=11037 (date first received May 1, 2015). ">TRC‐14004848</a>). Details of the ongoing trials are presented in the <a href="./references#CD012510-sec-0123" title="">Characteristics of ongoing studies</a> tables. </p> <p>We contacted the authors of all included and ongoing studies to request study data.</p> </section> <section id="CD012510-sec-0071"> <h4 class="title">Excluded studies</h4> <p>We excluded seven studies from our review (<a href="./references#CD012510-bbs2-0004" title="BosiersM , DelooseK , CallaertJ , VerbistJ , HendriksJ , LauwersP , et al. Superiority of stent‐grafts for in‐stent restenosis in the superficial femoral artery: twelve‐month results from a multicenter randomized trial. Journal of Endovascular Therapy2015;22(1):1‐10. ">Bosiers 2015</a>; <a href="./references#CD012510-bbs2-0005" title="AlbrechtT , MeyerD , Müller‐HülsbeckS , OttI , RedlichU , RickeJ , et al. Preliminary angiographic and clinical 6‐month results of the CONSEQUENT trial. The Leipig Interventional Course. Leipzig 26‐29 January 2016. NCT01970579 . Clinical trial on peripheral arteries treated with SeQuent® Please P Paclitaxel coated balloon catheter (ConSeQuent). clinicaltrials.gov/ct2/show/NCT01970579 (date first received October 28, 2013). ">ConSeQuent</a>; <a href="./references#CD012510-bbs2-0006" title="LiistroF , AngioliP , PortoI , RicciL , DucciK , GrottiS , et al. Paclitaxel‐eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in‐stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE‐ISR study. Journal of Endovascular Therapy2014;21(1):1‐8. ">DEBATE‐ISR</a>; <a href="./references#CD012510-bbs2-0007" title="DippelEJ , MakamP , KovachR , GeorgeJC , PatlolaR , MetzgerDC , et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in‐stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In‐Stent Restenosis). JACC.Cardiovascular interventions2015;8:92‐101. DippelEJ , MakamP , KovachRC , GeorgeJC , et al. EXCITE ISR: a prospective, randomized controlled trial of Excimer laser atherectomy vs balloon angioplasty for the treatment of femoropopliteal in‐stent restenosis. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl 11. NCT01330628 . Randomized study of laser and balloon angioplasty versus balloon angioplasty to treat peripheral in‐stent restenosis (EXCITE ISR). clinicaltrials.gov/ct2/show/NCT01330628 (date first received April 7, 2011). ">EXCITE ISR</a>; <a href="./references#CD012510-bbs2-0008" title="NCT00481780 . Conventional balloon angioplasty vs. cutting balloon angioplasty for treatment of femoropopliteal artery in‐stent restenosis ‐ a randomized controlled pilot trial. clinicaltrials.gov/ct2/show/NCT00481780 (date first received June 4, 2007). ">NCT00481780</a>; <a href="./references#CD012510-bbs2-0009" title="NCT02832024 . Clinical study of stent versus direct atherectomy versus angioplasty to treat lower limb in‐stent restenosis. clinicaltrials.gov/ct2/show/NCT02832024 (date first received July 13, 2016). ">NCT02832024</a>; <a href="./references#CD012510-bbs2-0010" title="DelooseK . RELINE randomized clinical trial: Viabahn covered stents vs PTA. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. NCT01108861 . GORE VIABAHN® versus plain old balloon angioplasty (POBA) for superficial femoral artery (SFA) in‐stent restenosis (RELINE). clinicaltrials.gov/ct2/show/NCT01108861 (date first received April 22, 2010). ">RELINE</a>), and we listed reasons for exclusion in the <a href="./references#CD012510-sec-0122" title="">Characteristics of excluded studies</a> tables. We excluded studies because they compared stenting in <a href="./references#CD012510-bbs2-0004" title="BosiersM , DelooseK , CallaertJ , VerbistJ , HendriksJ , LauwersP , et al. Superiority of stent‐grafts for in‐stent restenosis in the superficial femoral artery: twelve‐month results from a multicenter randomized trial. Journal of Endovascular Therapy2015;22(1):1‐10. ">Bosiers 2015</a> and <a href="./references#CD012510-bbs2-0010" title="DelooseK . RELINE randomized clinical trial: Viabahn covered stents vs PTA. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. NCT01108861 . GORE VIABAHN® versus plain old balloon angioplasty (POBA) for superficial femoral artery (SFA) in‐stent restenosis (RELINE). clinicaltrials.gov/ct2/show/NCT01108861 (date first received April 22, 2010). ">RELINE</a>, laser atherectomy in <a href="./references#CD012510-bbs2-0007" title="DippelEJ , MakamP , KovachR , GeorgeJC , PatlolaR , MetzgerDC , et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in‐stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In‐Stent Restenosis). JACC.Cardiovascular interventions2015;8:92‐101. DippelEJ , MakamP , KovachRC , GeorgeJC , et al. EXCITE ISR: a prospective, randomized controlled trial of Excimer laser atherectomy vs balloon angioplasty for the treatment of femoropopliteal in‐stent restenosis. Journal of the American College of Cardiology2014; Vol. 64, issue Suppl 11. NCT01330628 . Randomized study of laser and balloon angioplasty versus balloon angioplasty to treat peripheral in‐stent restenosis (EXCITE ISR). clinicaltrials.gov/ct2/show/NCT01330628 (date first received April 7, 2011). ">EXCITE ISR</a>, or cutting balloon angioplasty in <a href="./references#CD012510-bbs2-0008" title="NCT00481780 . Conventional balloon angioplasty vs. cutting balloon angioplasty for treatment of femoropopliteal artery in‐stent restenosis ‐ a randomized controlled pilot trial. clinicaltrials.gov/ct2/show/NCT00481780 (date first received June 4, 2007). ">NCT00481780</a> versus uncoated balloon angioplasty for in‐stent restenosis. The <a href="./references#CD012510-bbs2-0005" title="AlbrechtT , MeyerD , Müller‐HülsbeckS , OttI , RedlichU , RickeJ , et al. Preliminary angiographic and clinical 6‐month results of the CONSEQUENT trial. The Leipig Interventional Course. Leipzig 26‐29 January 2016. NCT01970579 . Clinical trial on peripheral arteries treated with SeQuent® Please P Paclitaxel coated balloon catheter (ConSeQuent). clinicaltrials.gov/ct2/show/NCT01970579 (date first received October 28, 2013). ">ConSeQuent</a> trial compared DEB versus uncoated balloon angioplasty for native vessel restenosis rather than in‐stent restenosis. The <a href="./references#CD012510-bbs2-0006" title="LiistroF , AngioliP , PortoI , RicciL , DucciK , GrottiS , et al. Paclitaxel‐eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in‐stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE‐ISR study. Journal of Endovascular Therapy2014;21(1):1‐8. ">DEBATE‐ISR</a> study compared a prospective cohort of patients receiving DEB therapy for in‐stent restenosis against a historical cohort of diabetic patients. Finally, the <a href="./references#CD012510-bbs2-0009" title="NCT02832024 . Clinical study of stent versus direct atherectomy versus angioplasty to treat lower limb in‐stent restenosis. clinicaltrials.gov/ct2/show/NCT02832024 (date first received July 13, 2016). ">NCT02832024</a> study compared stent deployment versus atherectomy versus uncoated balloon angioplasty alone for in‐stent restenosis. </p> </section> </section> <section id="CD012510-sec-0072"> <h3 class="title">Risk of bias in included studies</h3> <p>Please refer to the "Risk of bias" tables in the <a href="./references#CD012510-sec-0121" title="">Characteristics of included studies</a> tables and summary results in <a href="#CD012510-fig-0002">Figure 2</a> and <a href="#CD012510-fig-0003">Figure 3</a>. All three included studies were at a high risk of performance and attrition bias because of significant differences in bailout stenting rates and lack of clarity on the types of stents treated for in‐stent restenosis. </p> <div class="figure" id="CD012510-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012510-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012510-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012510-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012510-sec-0073"> <h4 class="title">Allocation</h4> <p>The included studies were at low risk of selection bias in random sequence generation or allocation concealment. The <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> trial used a block randomization study design with a block size of 10 and an allocation ratio of 1:1, and concealed the allocation sequence from investigators by using sequentially numbered and opaque sealed envelopes. The <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a> study used computer sequence generation to randomize participants after making the decision to proceed with an intervention. These researchers similarly accomplished the allocation of treatment by using sealed and opaque envelopes. The <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> trial investigators used a 1:1 randomization protocol with computer‐generated sequences and concealed allocation via use of sealed envelopes. </p> </section> <section id="CD012510-sec-0074"> <h4 class="title">Blinding</h4> <p>All three included studies were at high risk of performance bias because the operators were not blinded (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). Conversely, however, the outcomes assessors in two trials were blinded to the treatment arm (<a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>), placing them at low risk for detection bias. It is unclear whether the outcomes assessors in the <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> trial were blinded to the treatment arm. </p> </section> <section id="CD012510-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p>All three included studies were at high risk of attrition bias due to loss to follow‐up (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). In the <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> trial, approximately one‐third of participants were lost to follow‐up at 12 months. Similarly, in the <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a> trial, approximately 25% of DEB participants and 21% of uncoated balloon angioplasty participants did not undergo angiography as per the trial's primary endpoint requirement. In the <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> trial, eight participants in the DEB group (23%) and six in the uncoated balloon angioplasty group (15%) were lost to follow‐up. </p> </section> <section id="CD012510-sec-0076"> <h4 class="title">Selective reporting</h4> <p>All three included studies were at low risk for reporting bias (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). Trial authors reported all outcomes that were specified in the study protocols. </p> </section> <section id="CD012510-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p>Two major sources of bias in all included trials were specifying the types of stents treated for in‐stent restenosis and addressing the differences in bailout stenting requirements between treatment arms (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). </p> <p>Study authors did not specify whether stents that were treated were bare‐metal, covered, or drug‐eluting, nor did they stratify the results by length of the stent or duration of time since stent implantation. </p> <p>The other major source of bias is the disparity in the incidence of bailout stenting between treatment arms in all three included studies. In the <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> study, four uncoated balloon angioplasty participants received bailout stenting compared with one participant in the DEB arm. Conversely, in the <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a> study, 26% of DEB participants received bailout stenting compared with 6% of uncoated balloon angioplasty participants (P = 0.02). In the <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> study, four DEB participants received bailout stenting compared with one uncoated balloon angioplasty participant. Authors of the included studies did not stratify reported results by bailout stent implantation status. </p> <p>Furthermore, study populations in the <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> trial were not similar, as the uncoated balloon angioplasty group reported more advanced lesions (Tosaka II and TASC B and C) than were noted in the DEB group (67% Tosaka class II lesions in the uncoated balloon angioplasty group vs 46% in the DEB group, 36% TASC B and 26% TASC C lesions in the uncoated balloon angioplasty group vs 23% and 14% in the uncoated balloon angioplasty group, respectively). </p> </section> </section> <section id="CD012510-sec-0078"> <h3 class="title" id="CD012510-sec-0078">Effects of interventions</h3> <p>See: <a href="./full#CD012510-tbl-0001"><b>Summary of findings for the main comparison</b> Drug‐eluting balloon angioplasty at 6 months compared to uncoated balloon angioplasty at 6 months for in‐stent restenosis of the femoropopliteal arteries</a> </p> <section id="CD012510-sec-0079"> <h4 class="title">Primary outcomes</h4> <section id="CD012510-sec-0080"> <h5 class="title">Amputation‐free survival</h5> <p>None of the included studies reported amputation‐free survival (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). </p> <section id="CD012510-sec-0081"> <h6 class="title">Amputation</h6> <p>The three included studies reported no major or minor lower extremity amputations at one, six, 12, or 24 months of follow‐up (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). We judged the certainty of evidence to be very low, however, as none of the included trials were powered to detect differences in clinical endpoints such as amputation, and all of the included trials were at significant risk of performance and attrition bias. </p> </section> </section> <section id="CD012510-sec-0082"> <h5 class="title">Vessel patency</h5> <section id="CD012510-sec-0083"> <h6 class="title">Primary vessel patency</h6> <p>One study reported primary vessel patency (<a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). Study authors defined primary vessel patency as a &lt; 50% reduction in diameter stenosis by colored duplex ultrasound and reported no statistically significant differences between DEB and uncoated balloon angioplasty treatment arms. Study authors reported that primary vessel patency was 97.1% (95% confidence interval (CI) 0.91 to 1.00), 58.8% (95% CI 0.44 to 0.78), and 40.7% (95% CI 0.25 to 0.64) in the DEB group, and 97.1% (95% CI 0.91 to 1.00), 31.3% (95% CI 0.18 to 0.52), and 13.4% (95% CI 0.05 to 0.36) in the uncoated balloon angioplasty group at one, six, and 12 months, respectively. Study authors did not report the number of participants included in the calculations, however, so it is not possible to determine whether these percentages were calculated using an intention‐to‐treat analysis, nor could we perform a pooled analysis of trial results. </p> </section> <section id="CD012510-sec-0084"> <h6 class="title">Secondary vessel patency</h6> <section id="CD012510-sec-0085"> <p><b>Late lumen loss</b></p> <p>None of the included studies reported late lumen loss (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). </p> </section> <section id="CD012510-sec-0086"> <p><b>Target lesion revascularization</b></p> <p>One study reported TLR at six and 24 months of follow‐up (<a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>). At six months, participants treated with DEB had lower odds of requiring TLR compared with participants who underwent uncoated balloon angioplasty (<a href="./references#CD012510-fig-0005" title="">Analysis 2.1</a>; odds ratio (OR) 0.05, 95% CI 0.00 to 0.92; 70 participants; 1 study; very low‐certainty evidence). Similarly, at 24 months, participants treated with DEB had lower odds of requiring TLR compared with participants who underwent uncoated balloon angioplasty (<a href="./references#CD012510-fig-0012" title="">Analysis 4.1</a>; OR 0.24, 95% CI 0.08 to 0.70; 70 participants; 1 study). </p> </section> <section id="CD012510-sec-0087"> <p><b>Freedom from target lesion revascularization</b></p> <p>Two studies reported freedom from TLR at six and 12 months (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). In the <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> trial, freedom from TLR at six months was reported as 96.4% ± 3% standard error (SE) for DEB, and as 81% ± 5% SE for uncoated balloon angioplasty (P = 0.0117). At 12 months, freedom from TLR was reported as 90.8% ± 6% SE for DEB and 52.6% ± 10% SE for uncoated balloon angioplasty (P &lt; 0.0001). The <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> trial reported freedom from TLR as 88.2% (95% CI 0.78 to 0.99) at six months for DEB and 83.8% (95% CI 0.72 to 0.97) for uncoated balloon angioplasty. At 12 months, study authors reported freedom from TLR as 49% (95% CI 0.32 to 0.75) for DEB and 22.1% (95% CI 0.10 to 0.47) for uncoated balloon angioplasty. Study authors did not report the number of participants included in the calculations, however, so it is not possible to determine whether these percentages were calculated using an intention‐to‐treat analysis, nor could we perform a pooled analysis of trial results. </p> </section> <section id="CD012510-sec-0088"> <p><b>Binary restenosis rate</b></p> <p>Two studies reported binary restenosis at six months (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>), and one study reported binary restenosis at 12 months (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>). The <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> trial authors defined binary restenosis as a peak systolic velocity ratio ≥ 2.4 by duplex ultrasound, and the <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a> trial authors did not list their criteria for binary restenosis. At six months, participants treated with DEB had significantly lower odds of binary restenosis compared with those treated with uncoated balloon angioplasty (<a href="./references#CD012510-fig-0006" title="">Analysis 2.2</a>; OR 0.28, 95% CI 0.14 to 0.56; 189 participants; 2 studies; very low‐certainty evidence). Similarly, at 12 months, participants treated with DEB had significantly lower odds of binary restenosis compared with those treated with uncoated balloon angioplasty (OR 0.34, 95% CI 0.15 to 0.76; 119 participants; 1 study). </p> </section> </section> </section> <section id="CD012510-sec-0089"> <h5 class="title">Death</h5> <p>All three included studies reported death at six months (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>), two studies reported death at 12 months (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>), and one study reported death at 24 months (<a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>). The <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> study did not report any deaths during the course of the study for participants treated with DEB or uncoated balloon angioplasty. At six months, DEB showed no mortality advantage over uncoated balloon angioplasty (<a href="./references#CD012510-fig-0007" title="">Analysis 2.3</a>; OR 0.93, 95% CI 0.13 to 6.71; 263 participants; 3 studies; very low‐certainty evidence). Similarly, DEB offered no mortality advantage over uncoated balloon angioplasty at 12 months (<a href="./references#CD012510-fig-0010" title="">Analysis 3.2</a>; OR 0.60, 95% CI 0.10 to 3.73; 193 participants; 2 studies) nor at 24 months (<a href="./references#CD012510-fig-0013" title="">Analysis 4.2</a>; OR 7.21, 95% CI 0.36 to 144.95; 70 participants; 1 study). </p> </section> </section> <section id="CD012510-sec-0090"> <h4 class="title">Secondary outcomes</h4> <section id="CD012510-sec-0091"> <h5 class="title">Change in Rutherford category of PAD</h5> <p>None of the included studies reported the change in category of PAD (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). However, the <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> trial reported the number of participants who had improvement ≥ 1 Rutherford category at one, six, and 12 months, and the <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> trial reported the number of participants who experienced improvement ≥ 1 Rutherford category at six months. At one month, DEB showed no advantage over uncoated balloon angioplasty for participants experiencing improvement ≥ 1 Rutherford category (<a href="./references#CD012510-fig-0004" title="">Analysis 1.1</a>; OR 2.33, 95% CI 0.55 to 9.83; 74 participants; 1 study). However, participants treated with DEB had significantly greater odds of experiencing improvement ≥ 1 Rutherford category at six months (<a href="./references#CD012510-fig-0008" title="">Analysis 2.4</a>; OR 1.81, 95% CI 1.02 to 3.21; 193 participants; 2 studies; very low‐certainty evidence) and at 12 months (<a href="./references#CD012510-fig-0011" title="">Analysis 3.3</a>; OR 2.08, 95% CI 1.13 to 3.83; 193 participants; 2 studies). </p> </section> <section id="CD012510-sec-0092"> <h5 class="title">Change in the Society for Vascular Surgery Wound, Ischemia, and Foot Infection (WIfI) stage </h5> <p>None of the included studies reported change in WIfi stage (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). </p> </section> <section id="CD012510-sec-0093"> <h5 class="title">Change in ankle‐brachial index (ABI)</h5> <p>None of the included studies reported change in ABI (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). Two studies reported ABI at baseline (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>), and one study reported ABI at one month (<a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). Both the <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> and <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> studies reported ABI at six and 12 months. The mean ABI at baseline was 0.63 ± 0.27 for DEB participants and 0.64 ± 0.25 for uncoated balloon angioplasty participants in the <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> trial, and 0.65 ± 0.16 for DEB participants and 0.65 ± 0.16 for uncoated balloon angioplasty participants in the <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> trial. At one month, the mean ABI was 0.88 ± 0.14 for DEB participants and 0.9 ± 0.13 for uncoated balloon angioplasty participants in the <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> trial. At six months, the mean ABI was 0.9 ± 0.25 for DEB participants and 0.86 ± 0.3 for uncoated balloon angioplasty participants in the <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> trial, and 0.79 ± 0.13 for DEB participants and 0.78 ± 0.18 in the <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> trial. At 12 months, the mean ABI was 0.86 ± 0.3 for DEB participants and 0.9 ± 0.17 for uncoated balloon angioplasty participants in the <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> trial, and 0.79 ± 0.2 for DEB participants and 0.84 ± 0.3 for uncoated balloon angioplasty participants in the <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> trial. The authors of both the <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> and <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a> studies did not report the number of participants included in the calculations, however, so it is not possible to determine whether these percentages were calculated using an intention‐to‐treat analysis, nor could we perform a pooled analysis of trial results. </p> </section> <section id="CD012510-sec-0094"> <h5 class="title">Change in quality of life (QoL) scores</h5> <p>None of the included studies reported change in QoL scores (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). </p> </section> <section id="CD012510-sec-0095"> <h5 class="title">Change in functional walking ability</h5> <p>None of the included studies reported change in functional walking ability (<a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a>; <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a>; <a href="./references#CD012510-bbs2-0003" title="KinstnerCM , LammerJ , Willfort‐EhringerA , MatzekW , GschwandtnerM , JavorD , et al. Paclitaxel‐eluting balloon versus standard balloon angioplasty in in‐stent restenosis of the superficial femoral and proximal popliteal artery: 1‐year results of the PACUBA trial. JACC Cardiovascular Interventions2016;9(13):1386‐92. KinstnerCM , SchoderM , FunovicsMA , Willfort‐EhringerA , GschwandtnerM , RistlR , et al. A monocenter randomized clinical trial of PAClitaxel drUgeluting Balloon versus standard percutaneous transluminal Angioplasty to reduce restenosis in patients with in‐stent stenoses in the superficial femoral and proximal popliteal artery (PACUBA I Trial). Cardiovascular and Interventional Radiology2015;38(3 Suppl 1):S288. NCT01247402 . Paclitaxel balloon versus standard balloon in in‐stent restenoses of the superficial femoral artery (PACUBA I Trial) (PACUBA 1). clinicaltrials.gov/ct2/show/NCT01247402 (date first received November 24, 2010). ">PACUBA</a>). </p> </section> </section> <section id="CD012510-sec-0096"> <h4 class="title">Subgroup analysis</h4> <p>It is not possible to carry out a subgroup analysis, as data were not available from more than two trials for any of the reported outcomes. </p> </section> <section id="CD012510-sec-0097"> <h4 class="title">Sensitivity analysis</h4> <p>It is not possible to carry out a sensitivity analysis because of the small number of included studies and the discrepancy in time points at which included studies reported outcomes. Furthermore, none of the included studies were powered to detect clinical endpoints, and several of our pre‐specified outcomes were not reported. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012510-sec-0098" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012510-sec-0098"></div> <section id="CD012510-sec-0099"> <h3 class="title" id="CD012510-sec-0099">Summary of main results</h3> <p>Drug‐eluting balloon (DEB) angioplasty was associated with lower odds of requiring target lesion revascularization (TLR) for up to 24 months and lower rates of binary restenosis for up to 12 months when compared with uncoated balloon angioplasty for treatment of symptomatic in‐stent restenosis. The drug‐eluting balloon was also associated with greater odds of improvement in the Rutherford category of peripheral arterial disease (PAD) for up to 12 months when compared with uncoated balloon angioplasty. We noted no clear difference in amputation or mortality between DEB and uncoated balloon angioplasty at up to 24 months of follow‐up. Because of lack of reporting, evidence was insufficient to suggest an advantage for DEB in primary vessel patency; amputation‐free survival; late lumen loss; change in Society for Vascular Surgery Wound, Ischemia, and Foot Infection (WIfI) stage; ankle‐brachial index (ABI); quality of life (QoL) scores; or functional walking ability when compared with uncoated balloon angioplasty for treatment of in‐stent restenosis. Data from the three included trials were also insufficient for performance of subgroup or sensitivity analyses. </p> </section> <section id="CD012510-sec-0100"> <h3 class="title" id="CD012510-sec-0100">Overall completeness and applicability of evidence</h3> <p>All studies reported on symptomatic in‐stent restenosis. All included studies reported a number of anatomical and clinical outcomes that are relevant to practitioners who treat in‐stent restenosis. Unfortunately, all included studies had significant limitations (listed in <a href="#CD012510-sec-0072">Risk of bias in included studies</a>). All three trials were at high risk of bias due to significant losses of participants to follow‐up, lack of blinding, and lack of stratification by type of stent implanted and requirement for bailout stenting. Use of TLR as an outcome measure is also potentially problematic, as it is a highly subjective measure that makes it difficult to standardize who will be offered a reintervention. Similarly, change in Rutherford category is a highly subjective measure, and it does not seem that any of the included trials used objective measures, such as treadmill testing, to enable determination of Rutherford category. Most of the participants in the trial did not have evidence of critical limb ischemia, as defined by a Rutherford category ≥ 4, which is the main indication for many physicians in treating peripheral arterial disease. Furthermore, it is not possible to perform any subgroup analyses nor to exclude any trials from a sensitivity analysis. Finally, the included studies did not assess many of the pre‐planned outcomes identified in our study protocol, and some of the outcomes data, such as the ABI, were not amenable to pooled analysis because of the format in which they were reported. Given that we identified at least two ongoing studies (listed in <a href="./references#CD012510-bbs1-0003" title="">Ongoing studies</a>), we are hopeful that it will become possible someday to carry out a more rigorous examination of the role of DEB in treating in‐stent restenosis. </p> </section> <section id="CD012510-sec-0101"> <h3 class="title" id="CD012510-sec-0101">Quality of the evidence</h3> <p>This review was based on three studies that recruited a relatively small number of participants and were powered primarily to detect anatomical rather than clinical outcomes. However, all analyses in this review are based on data from a single trial or from two trials. As such, caution should be taken in over‐interpreting clinical findings, such as the incidence of amputation or change in ABI. Studies used two DEBs with different paclitaxel doses, and two of the three studies were sponsored by a DEB manufacturer (Medtronic). Unfortunately, the included studies did not report most of the outcomes that we identified as important in this review. Finally, all three studies were at high risk of performance, attrition, and other biases, and this negatively impacts the overall quality of the evidence. </p> <p>See <a href="./full#CD012510-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD012510-sec-0102"> <h3 class="title" id="CD012510-sec-0102">Potential biases in the review process</h3> <p>We carried out this review according to the principles outlined in the Cochrane guidelines. We encountered difficulty obtaining data from the <a href="./references#CD012510-bbs2-0001" title="KrankenbergH . FAIR drug eluting balloon vs. PTA for superficial femoral artery in‐stent restenosis 12‐month results. The Leipzig Interventional Course. Leipzig 28‐31 January 2014. KrankenbergH , TüblerT , IngwersenM , SchlüterM , ScheinertD , BlessingE , et al. Drug‐coated balloon versus standard balloon for superficial femoral artery in‐stent restenosis: the randomized femoral artery in‐stent restenosis (FAIR) trial. Circulation2015;132(23):2230‐6. NCT01305070 . Standard balloon angioplasty versus angioplasty with a paclitaxel‐eluting balloon for Femoral Artery In‐stent Restenosis (FAIR). clinicaltrials.gov/ct2/show/NCT01305070 (date first received February 28, 2011). ">FAIR</a> and <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a> authors, as well as from authors of the ongoing studies (<a href="./references#CD012510-bbs2-0011" title="NCT01594684 . Cotavance™ paclitaxel‐coated balloon versus uncoated balloon angioplasty for treatment of in‐stent restenosis in SFA and popliteal arteries. clinicaltrials.gov/ct2/show/results/NCT01594684 (date first received May 9, 2012). ">Copa Cabana</a>; <a href="./references#CD012510-bbs2-0012" title="ChiCTR‐TRC‐14004848 . Drug‐eluting balloon versus standard balloon angioplasty for the treatment of in‐stent restenosis in the femoral‐popliteal artery: a randomized, controlled prospective study. chictr.org.cn/hvshowproject.aspx?id=11037 (date first received May 1, 2015). ">TRC‐14004848</a>). Because of the limited number of studies included in this review, we were unable to carry out any subgroup or sensitivity analyses. </p> </section> <section id="CD012510-sec-0103"> <h3 class="title" id="CD012510-sec-0103">Agreements and disagreements with other studies or reviews</h3> <p>We identified two systematic reviews that examined the role of DEB for in‐stent restenosis (<a href="./references#CD012510-bbs2-0017" title="CasseseS , NdrepepaG , KufnerS , ByrneRA , GiacoppoD , OttI , et al. Drug‐coated balloon angioplasty for in‐stent restenosis of femoropopliteal arteries: a meta‐analysis. EuroIntervention2017;13(4):483‐9. ">Cassese 2017</a>; <a href="./references#CD012510-bbs2-0035" title="WuR , LiZ , WangM , ChangG , YaoC , WangS . Paclitaxel‐coated versus uncoated balloon angioplasty for femoropopliteal artery in‐stent restenosis. International Journal of Surgery2017;42:72‐82. ">Wu 2017</a>). <a href="./references#CD012510-bbs2-0017" title="CasseseS , NdrepepaG , KufnerS , ByrneRA , GiacoppoD , OttI , et al. Drug‐coated balloon angioplasty for in‐stent restenosis of femoropopliteal arteries: a meta‐analysis. EuroIntervention2017;13(4):483‐9. ">Cassese 2017</a>, the first review, similarly reported superior outcomes with DEB compared with uncoated balloon angioplasty in TLR and binary restenosis, and showed significant improvement in Rutherford category. The Cassese review differs from our review on several points, however. First, the <a href="./references#CD012510-bbs2-0017" title="CasseseS , NdrepepaG , KufnerS , ByrneRA , GiacoppoD , OttI , et al. Drug‐coated balloon angioplasty for in‐stent restenosis of femoropopliteal arteries: a meta‐analysis. EuroIntervention2017;13(4):483‐9. ">Cassese 2017</a> review authors chose to include a non‐randomized study that we excluded (<a href="./references#CD012510-bbs2-0006" title="LiistroF , AngioliP , PortoI , RicciL , DucciK , GrottiS , et al. Paclitaxel‐eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in‐stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE‐ISR study. Journal of Endovascular Therapy2014;21(1):1‐8. ">DEBATE‐ISR</a>), along with unpublished data from the <a href="./references#CD012510-bbs2-0011" title="NCT01594684 . Cotavance™ paclitaxel‐coated balloon versus uncoated balloon angioplasty for treatment of in‐stent restenosis in SFA and popliteal arteries. clinicaltrials.gov/ct2/show/results/NCT01594684 (date first received May 9, 2012). ">Copa Cabana</a> trial, which we have not been able to verify. Furthermore, <a href="./references#CD012510-bbs2-0017" title="CasseseS , NdrepepaG , KufnerS , ByrneRA , GiacoppoD , OttI , et al. Drug‐coated balloon angioplasty for in‐stent restenosis of femoropopliteal arteries: a meta‐analysis. EuroIntervention2017;13(4):483‐9. ">Cassese 2017</a> authors did not include <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a> in the analysis. Second, review authors for <a href="./references#CD012510-bbs2-0017" title="CasseseS , NdrepepaG , KufnerS , ByrneRA , GiacoppoD , OttI , et al. Drug‐coated balloon angioplasty for in‐stent restenosis of femoropopliteal arteries: a meta‐analysis. EuroIntervention2017;13(4):483‐9. ">Cassese 2017</a> did not specify the time points at which the analysis was carried out, electing instead to report outcomes for the included studies at an unspecified time point. As such, it is not possible to assess whether their reported improvement in TLR, for example, occurred at six or 12 months, because the studies that they included in their analysis reported outcomes at different time points. </p> <p>The second systematic review also reported superior outcomes with DEB compared with uncoated balloon angioplasty in TLR and binary restenosis, as well as clinical improvement (<a href="./references#CD012510-bbs2-0035" title="WuR , LiZ , WangM , ChangG , YaoC , WangS . Paclitaxel‐coated versus uncoated balloon angioplasty for femoropopliteal artery in‐stent restenosis. International Journal of Surgery2017;42:72‐82. ">Wu 2017</a>), which, in our study, we identified as a positive change in Rutherford category. However, <a href="./references#CD012510-bbs2-0035" title="WuR , LiZ , WangM , ChangG , YaoC , WangS . Paclitaxel‐coated versus uncoated balloon angioplasty for femoropopliteal artery in‐stent restenosis. International Journal of Surgery2017;42:72‐82. ">Wu 2017</a> also included <a href="./references#CD012510-bbs2-0006" title="LiistroF , AngioliP , PortoI , RicciL , DucciK , GrottiS , et al. Paclitaxel‐eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in‐stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE‐ISR study. Journal of Endovascular Therapy2014;21(1):1‐8. ">DEBATE‐ISR</a> in the analysis (which we excluded because it is non‐randomized) and did not include data from the <a href="./references#CD012510-bbs2-0002" title="NCT01083394 . Paclitaxel eluting balloon and conventional balloon for in‐stent restenosis of the superficial femoral artery (ISAR‐PEBIS). clinicaltrials.gov/ct2/show/NCT01083394 (date first received March 9, 2010). OttI , CasseseS , GrohaP , SteppichB , VollF , HadamitzkyM , et al. ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial. Journal of the American Heart Association2017;6(7):pii: e006321. ">ISAR‐PEBIS</a> trial. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012510-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012510-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012510-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012510-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 1 month, Outcome 1 Improvement ≥ 1 Rutherford category." data-id="CD012510-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 1 month, Outcome 1 Improvement ≥ 1 Rutherford category. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 6 months, Outcome 1 Target lesion revascularization." data-id="CD012510-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 6 months, Outcome 1 Target lesion revascularization. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 6 months, Outcome 2 Binary restenosis." data-id="CD012510-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 6 months, Outcome 2 Binary restenosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 6 months, Outcome 3 Death." data-id="CD012510-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 6 months, Outcome 3 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 6 months, Outcome 4 Improvement ≥ 1 Rutherford category." data-id="CD012510-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 6 months, Outcome 4 Improvement ≥ 1 Rutherford category. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 12 months, Outcome 1 Binary restenosis." data-id="CD012510-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 12 months, Outcome 1 Binary restenosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 12 months, Outcome 2 Death." data-id="CD012510-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 12 months, Outcome 2 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 12 months, Outcome 3 Improvement ≥ 1 Rutherford category." data-id="CD012510-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 12 months, Outcome 3 Improvement ≥ 1 Rutherford category. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 24 months, Outcome 1 Target lesion revascularization." data-id="CD012510-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 24 months, Outcome 1 Target lesion revascularization. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012510-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/urn:x-wiley:14651858:media:CD012510:CD012510-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_t/tCD012510-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 24 months, Outcome 2 Death." data-id="CD012510-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 24 months, Outcome 2 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/media/CDSR/CD012510/image_n/nCD012510-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012510-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Drug‐eluting balloon angioplasty at 6 months compared to uncoated balloon angioplasty at 6 months for in‐stent restenosis of the femoropopliteal arteries</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Drug‐eluting balloon angioplasty at 6 months compared to uncoated balloon angioplasty at 6 months for in‐stent restenosis of the femoropopliteal arteries</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> patients with in‐stent restenosis of the femoropopliteal arteries<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> drug‐eluting balloon angioplasty at 6 months<br/> <b>Comparison:</b> uncoated balloon angioplasty at 6 months </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with uncoated balloon angioplasty</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with drug‐eluting balloon angioplasty</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Amputation</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>263</p> <p>(3 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> VERY LOW<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None of the 3 included studies reported any major or minor amputations during follow‐up. Amputation‐free survival was not an outcome in the included studies </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Target lesion revascularization (TLR)<br/> Follow‐up: 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.05<br/> (0.00 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>206 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000<br/> (0 to 193) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Binary restenosis<br/> Follow‐up: 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.28<br/> (0.14 to 0.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>189<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>407 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>161 per 1000<br/> (88 to 277) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Death</p> <p>Follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>OR 0.93<br/> (0.13 to 6.71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>263</p> <p>(3 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊝⊝<br/> VERY LOW<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>8 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>7 per 1000</p> <p>(1 to 49)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Improvement ≥ 1 Rutherford category<br/> Follow‐up: 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.81<br/> (1.02 to 3.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>193<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>427 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>574 per 1000<br/> (432 to 705) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> CI: confidence interval; OR: odds ratio; RCT: randomized controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by three levels because of significant risk of performance and attrition bias, the small numbers of studies and participants, and other biases due to lack of accounting for the type of stent being treated and need for bailout stenting. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Drug‐eluting balloon angioplasty at 6 months compared to uncoated balloon angioplasty at 6 months for in‐stent restenosis of the femoropopliteal arteries</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/full#CD012510-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012510-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 1 month</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Improvement ≥ 1 Rutherford category <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.33 [0.55, 9.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 1 month</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012510-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 6 months</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Target lesion revascularization <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Binary restenosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.14, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.13, 6.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Improvement ≥ 1 Rutherford category <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.81 [1.02, 3.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 6 months</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012510-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 12 months</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Binary restenosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.15, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.10, 3.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Improvement ≥ 1 Rutherford category <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.08 [1.13, 3.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 12 months</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012510-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 24 months</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Target lesion revascularization <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.08, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.21 [0.36, 144.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Drug‐eluting balloon (DEB) versus uncoated balloon angioplasty at 24 months</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012510.pub2/references#CD012510-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012510.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012510-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012510-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012510-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD012510-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD012510-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD012510-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD012510-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012510-note-0012">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012510\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012510\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012510\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012510\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012510\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=p32VIvbS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012510.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012510.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012510.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012510.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012510.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725850544"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012510.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725850548"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012510.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e8550bf0a9371',t:'MTc0MDcyNTg1MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 